Featured

Partner confident the firm can navigate the ‘no growth to very low growth’ predicted in Europe.

BCLP's David Schwartz: 'The FTC has invested heavily in understanding and tracking private equity dealmaking in healthcare, and I do not see those investments being discarded just because of a change in administration.'

RiverGlade Capital, InTandem Capital Partners and FFL Partners are among the firms looking to capitalize on infusion service investments.

GTCR recently agreed to make a $1.33bn minority investment in Tricentis, to join the current investor Insight Partner in a deal that values the company at $4.5bn.

The private markets firm acquired Spain’s Bluesea, a hospitality platform, in late November.

'What differentiates the NFL from the other leagues is higher revenues, higher valuations and cashflow,' says Park Lane's Sean Clemens.

Pinnacle Investment Management, an Australian Securities Exchange-listed multi-affiliate investment management group, is taking a 22.5 percent interest in VSS Capital.

'As inflation cools and interest rates potentially ease after 2024's period of elevated rates – easing only in the last couple of months – the economic landscape should be more supportive of dealmaking activity.'

Value creation will include M&A and a new management team, managing directors Olivier Lieven and Tobias Nordblom told PE Hub.

B2B service providers and targets with US-based manufacturing, transportation and logistics will command premiums, say West Monroe’s Brad Haller and Jeremy Tancredi.